Your browser doesn't support javascript.
loading
Defining High-Quality Palliative Care in Oncology Practice: An American Society of Clinical Oncology/American Academy of Hospice and Palliative Medicine Guidance Statement.
Bickel, Kathleen E; McNiff, Kristen; Buss, Mary K; Kamal, Arif; Lupu, Dale; Abernethy, Amy P; Broder, Michael S; Shapiro, Charles L; Acheson, Anupama Kurup; Malin, Jennifer; Evans, Tracey; Krzyzanowska, Monika K.
Affiliation
  • Bickel KE; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • McNiff K; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Buss MK; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Kamal A; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Lupu D; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Abernethy AP; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Broder MS; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Shapiro CL; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Acheson AK; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Malin J; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Evans T; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
  • Krzyzanowska MK; White River Junction VA Medical Center; Geisel School of Medicine at Dartmouth, White River Junction, VT; Dana-Farber Cancer Institute; Beth Israel Deaconess Medical Center, Boston, MA; Duke University Medical Center, Durham, NC; American Academy of Hospice and Palliative Medicine, Glenview, IL; Par
J Oncol Pract ; 12(9): e828-38, 2016 09.
Article in En | MEDLINE | ID: mdl-27531376
PURPOSE: Integrated into routine oncology care, palliative care can improve symptom burden, quality of life, and patient and caregiver satisfaction. However, not all oncology practices have access to specialist palliative medicine. This project endeavored to define what constitutes high-quality primary palliative care as delivered by medical oncology practices. METHODS: An expert steering committee outlined 966 palliative care service items, in nine domains, each describing a candidate element of primary palliative care delivery for patients with advanced cancer or high symptom burden. Using modified Delphi methodology, 31 multidisciplinary panelists rated each service item on three constructs: importance, feasibility, and scope within medical oncology practice. RESULTS: Panelists endorsed the highest proportion of palliative care service items in the domains of End-of-Life Care (81%); Communication and Shared Decision Making (79%); and Advance Care Planning (78%). The lowest proportions were in Spiritual and Cultural Assessment and Management (35%) and Psychosocial Assessment and Management (39%). In the largest domain, Symptom Assessment and Management, there was consensus that all symptoms should be assessed and managed at a basic level, with more comprehensive management for common symptoms such as nausea, vomiting, diarrhea, dyspnea, and pain. Within the Appropriate Palliative Care and Hospice Referral domain, there was consensus that oncology practices should be able to describe the difference between palliative care and hospice to patients and refer patients appropriately. CONCLUSION: This statement describes the elements comprising high-quality primary palliative care for patients with advanced cancer or high symptom burden, as delivered by oncology practices. Oncology providers wishing to enhance palliative care delivery may find this information useful to inform operational changes and quality improvement efforts.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Neoplasms Type of study: Guideline / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Oncol Pract Year: 2016 Document type: Article Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Palliative Care / Neoplasms Type of study: Guideline / Prognostic_studies Aspects: Patient_preference Limits: Humans Language: En Journal: J Oncol Pract Year: 2016 Document type: Article Country of publication: